SAYER KEVIN R 4
4 · DEXCOM INC · Filed Jan 17, 2024
Insider Transaction Report
Form 4
DEXCOM INCDXCM
SAYER KEVIN R
DirectorExecutive Chair
Transactions
- Sale
Common Stock
2024-01-16$123.63/sh−37,325$4,614,669→ 362,841 total - Award
Common Stock
2024-01-12$0.00/sh+72,709$73→ 400,166 total
Footnotes (3)
- [F1]Represents performance stock units ("PSUs") granted to the reporting person on March 8, 2021 that vested on January 12, 2024.
- [F2]Included in this number are 115,682 unvested restricted stock units, 54,422 of which were granted on March 9, 2023 and shall vest through March 8, 2026, 43,336 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 17,924 of which were granted on March 8, 2021 and shall vest through March 8, 2024.
- [F3]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.